n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with fluvoxamine in 6 studies
| Studies (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Trials (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Recent Studies (post-2010) (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Studies (fluvoxamine) | Trials (fluvoxamine) | Recent Studies (post-2010) (fluvoxamine) |
|---|---|---|---|---|---|
| 98 | 0 | 29 | 2,051 | 518 | 434 |
| Protein | Taxonomy | n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride (IC50) | fluvoxamine (IC50) |
|---|---|---|---|
| D | Rattus norvegicus (Norway rat) | 0.54 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0038 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.54 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, Y; Hashimoto, K; Iyo, M | 1 |
| Bhuiyan, MS; Fukunaga, K; Shioda, N; Tagashira, H | 1 |
| Bhuiyan, MS; Fukunaga, K; Tagashira, H | 1 |
| Kanazawa, M; Kubota, H; Mori, T; Rahmadi, M; Shibasaki, M; Suzuki, T | 1 |
| Balogh, D; Fekete, A; Hodrea, J; Hosszu, A; Koszegi, S; Lenart, L; Szabo, AJ; Szkibinszkij, E; Vannay, A; Veres-Szekely, A; Wagner, L; Zelena, D | 1 |
| Kamei, C; Karube, Y; Matsushima, Y; Sugimoto, Y; Takata, J; Terada, K | 1 |
6 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and fluvoxamine
| Article | Year |
|---|---|
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.
Topics: Analysis of Variance; Animals; Anisoles; Antipsychotic Agents; Behavior, Animal; Choice Behavior; Cognition Disorders; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Fluvoxamine; Mice; Mice, Inbred ICR; Motor Activity; Nootropic Agents; Phencyclidine; Piperazines; Propylamines; Receptors, sigma; Retention, Psychology; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor | 2007 |
Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions.
Topics: Animals; Anisoles; Blood Pressure; Cardiotonic Agents; Female; Fluvoxamine; Heart; Humans; Hypertrophy, Left Ventricular; Myocardium; Ovariectomy; Propylamines; Rats; Rats, Wistar; Receptors, Glycine; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor; Signal Transduction; Up-Regulation | 2010 |
Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding.
Topics: Animals; Anisoles; Aorta, Abdominal; Aorta, Thoracic; Aortic Valve Stenosis; Cardiomegaly; Dose-Response Relationship, Drug; Female; Fluvoxamine; Nitric Oxide Synthase Type III; Ovariectomy; Phosphorylation; Propylamines; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor; Signal Transduction | 2011 |
Involvement of sigma 1 receptor in the SSRI-induced suppression of the methamphetamine-induced behavioral sensitization and rewarding effects in mice.
Topics: Animals; Anisoles; Behavior, Animal; Disease Models, Animal; Fluvoxamine; Methamphetamine; Mice; Propylamines; Rats; Receptors, sigma; Reward; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor | 2013 |
The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats.
Topics: Animals; Anisoles; Brain; Brain-Derived Neurotrophic Factor; Depression; Depressive Disorder; Diabetes Mellitus, Experimental; Fluvoxamine; Male; Narcotic Antagonists; Propylamines; Rats; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor; Signal Transduction | 2016 |
Effects of fluvoxamine on nerve growth factor-induced neurite outgrowth inhibition by dexamethasone in PC12 cells.
Topics: Animals; Anisoles; Anti-Anxiety Agents; Cell Differentiation; Dexamethasone; Fluvoxamine; Gene Expression Regulation; Glucocorticoids; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Nerve Growth Factor; Neuronal Outgrowth; Neurons; PC12 Cells; Phosphorylation; Propylamines; Proto-Oncogene Proteins c-akt; Rats; Receptors, sigma; Sigma-1 Receptor; Signal Transduction | 2019 |